At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Flosealdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Floseal Posterior Epistaxis Pilot Study (PEPIS)
In Brief
A clinical study evaluating Floseal for Epistaxis. Completed, enrolled 20 participants.
Detailed Summary
Effectiveness of Floseal for the treatment of posterior epistaxis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEpistaxis
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2010
First PostedApr 2010
Primary CompletionNov 2011
TodayJul 2026
First PostedApr 2, 2010
Enrollment StartApr 1, 2010
Primary CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 16.3 years ago
Interventions
Flosealdrug
Received 1 syringe of Floseal as treatment for posterior epistaxis.